159 related articles for article (PubMed ID: 16230967)
1. [Antiviral vaccination and respiratory mucosal immunity: still disappointing results from a seductive idea].
Denis F; Alain S; Hantz S; Lagrange P
Presse Med; 2005 Oct; 34(17):1245-53. PubMed ID: 16230967
[TBL] [Abstract][Full Text] [Related]
2. [Immunity and antiviral vaccinations. Example: the respiratory mucosa].
Denis F; Hantz S; Alain S
Antibiotiques (Paris); 2007 May; 9(2):130-138. PubMed ID: 32288532
[TBL] [Abstract][Full Text] [Related]
3. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
[TBL] [Abstract][Full Text] [Related]
5. Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken.
Matoo JJ; Bashir K; Kumar A; Krishnaswamy N; Dey S; Chellappa MM; Ramakrishnan S
Microb Pathog; 2018 Jun; 119():119-124. PubMed ID: 29635053
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against acute respiratory virus infections and measles in man.
Osterhaus AD; de Vries P
Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
[TBL] [Abstract][Full Text] [Related]
7. [Mucosal immunity and vaccines against viral infections].
Zainutdinov SS; Sivolobova GF; Loktev VB; Kochneva GV
Vopr Virusol; 2022 Jan; 66(6):399-408. PubMed ID: 35019246
[TBL] [Abstract][Full Text] [Related]
8. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunity and viral infections.
Freihorst J; Ogra PL
Ann Med; 2001 Apr; 33(3):172-7. PubMed ID: 11370770
[TBL] [Abstract][Full Text] [Related]
10. Immunologic and virologic aspects of secretory immune system in human respiratory tract.
Ogra PL; Morag A
Dev Biol Stand; 1975; 28():129-44. PubMed ID: 47823
[TBL] [Abstract][Full Text] [Related]
11. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.
Yuan L; Saif LJ
Vet Immunol Immunopathol; 2002 Sep; 87(3-4):147-60. PubMed ID: 12072229
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
13. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
14. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
Kim S; Jang JE; Yu JR; Chang J
Vaccine; 2010 May; 28(22):3801-8. PubMed ID: 20362203
[TBL] [Abstract][Full Text] [Related]
15. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
[TBL] [Abstract][Full Text] [Related]
16. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
Front Immunol; 2018; 9():934. PubMed ID: 29770135
[TBL] [Abstract][Full Text] [Related]
17. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity.
Maier C; Fuchs J; Irrgang P; Wißing MH; Beyerlein J; Tenbusch M; Lapuente D
Front Immunol; 2022; 13():920256. PubMed ID: 36003372
[TBL] [Abstract][Full Text] [Related]
19. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and systemic immune responses to Aujeszky's disease virus (ADV) in early vaccinated piglets.
Salinas-Zacarias I; Guzman-Bautista ER; Ramírez-Estudillo MDC; Chacón-Salinas R; Vega-López MA
Comp Immunol Microbiol Infect Dis; 2020 Feb; 68():101400. PubMed ID: 31794953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
